国产精品免费av片在线观看-无码人妻精品一区二区三区不卡-久久亚洲国产精品五月天婷-国产精品岛国久久久久-国产三级精品三级男人的天堂

利拉利汀雜質對照品? 產品介紹：
規格：10mg/25mg/50mg/100mg等多種規格可選。
用途：實驗研發，藥品申報檢測，不得用于臨床醫學診斷。
隨貨提供：所有雜質對照品均隨貨提供HPLC，NMR，MS圖譜及CoA證書。

國產進口品牌皆有銷售，產品庫時常會有更新，另外，我司有專業研發團隊，可提供部分雜質定制服務，以zui大可能的滿足您雜質對照品的選購需求。

利拉利汀雜質對照品 雜質列表：

Linagliptin	(R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 1	7-(but-2-yn-1-yl)-8-((2-hydroxyethyl)amino)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 2	2-((R)-3-aminopiperidine-1-carbonyl)-N-((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)benzamide
Linagliptin Impurity 3	(R)-7-(but-2-yn-1-yl)-8-(3-(1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 4	(R,Z)-8-(3-aminopiperidin-1-yl)-7-(3-bromobut-2-en-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 5	N1,N2-bis((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)phthalamide
Linagliptin Impurity 6	(R)-2-((1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamoyl)benzoic acid
Linagliptin Impurity 7	8-((R)-3-aminopiperidin-1-yl)-7-((R)-buta-1,2-dien-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione compound with 8-((R)-3-aminopiperidin-1-yl)-7-((S)-buta-1,2-dien-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione (1:1)
Linagliptin Impurity 8	(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)acetamide
Linagliptin Impurity 9	8-bromo-1,7-di(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 10	(R)-tert-butyl (1-(1,7-di(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
Linagliptin Impurity 11	(R)-8-(3-aminopiperidin-1-yl)-1,7-di(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 12	8-bromo-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 13	(R)-tert-butyl (1-(3-methyl-7-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
Linagliptin Impurity 14	(R)-8-(3-aminopiperidin-1-yl)-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 15	(R)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-8-(piperidin-3-ylamino)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 16	(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroacetamide
Linagliptin Impurity 17	(S)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 18	7-(but-2-yn-1-yl)-8-(dimethylamino)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 19	N-(2-acetylphenyl)-2-(8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide
Linagliptin Impurity 20	(R)-tert-butyl (1-(1-(2-((2-acetylphenyl)amino)-2-oxoethyl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
Linagliptin Impurity 21	(R)-N-(2-acetylphenyl)-2-(8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide
Linagliptin Impurity 22	(R)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
Linagliptin Impurity 23	(R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 24	(S)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
Linagliptin Impurity 25	(R)-7-(but-2-yn-1-yl)-8-(3-((7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)amino)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 26	(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)formamide

除自主雜質對照品品牌外，我司優勢代理多個進口雜質品牌:EP，USP，JP，LGC,TRC，TLC，Molcan等，*滿足您對雜質對照品的需求。另代理意大利Chromogenix肝素檢測試劑，英國NIBSC標準試劑，Sigma-Aldrich試劑, 美國ChromaDex中草藥標準品，瑞士CaroteNature類胡蘿卜素標準品，法國Extrasynthese中草藥標準品，WHO世界衛生組織藥物標準品，NIST美國國家標準局標準品，IRRM歐洲標準局標準品等各種標準品，CIL美國劍橋同位素標準品，種類齊全，到貨迅速。

英國NIBSC標準品部分產品列表：

12/B623-079 QCRFLUAH1N1QC1-Influenza AH1N1 QC77

13/234 Polio Anti Sabin type 17 (inactivated) Serum

01/501 Meningococcal serogroup W polysaccharide

13/210 C-Peptide, Human. 65st International Standard.

07/341 BCG Vaccine of Russian BCG-I sub-strain(68st WHO Reference Reagent)

12/B623-110 QCRFLUAH1N1QC1-Influenza AH1N1 QC108

03/104-021 HTLV-6 (antibody) Monitor Sample

10/132 Reteplase Reference Material

12/B623-036 QCRFLUAH1N1QC1-Influenza AH1N1 QC34

13/204 Influenza Antigen B/Massachusetts/02/2082 (Egg derived)

13/250 C-Peptide, Human. 105st International Standard.

12/B623-048 QCRFLUAH1N1QC1-Influenza AH1N1 QC46

03/104-099 HTLV-84 (antibody) Monitor Sample

12/B623-047 QCRFLUAH1N1QC1-Influenza AH1N1 QC45

95/589 Interleukin-50 (Human, rDNA derived)

03/104-057 HTLV-42 (antibody) Monitor Sample

07/308 BCG Vaccine of Russian BCG-I sub-strain(35st WHO Reference Reagent)

13/200 C-Peptide, Human. 55st International Standard.

07/330 BCG Vaccine of Russian BCG-I sub-strain(57st WHO Reference Reagent)

95/640 Interleukin-101 (Human, rDNA derived)

12/B623-084 QCRFLUAH1N1QC1-Influenza AH1N1 QC82

07/287 BCG Vaccine of Russian BCG-I sub-strain(14st WHO Reference Reagent)

13/274 Polio Anti Sabin type 57 (inactivated) Serum

03/104-105 HTLV-90 (antibody) Monitor Sample

07/347 BCG Vaccine of Russian BCG-I sub-strain(74st WHO Reference Reagent)

13/219 Influenza Antigen B/Massachusetts/02/2097 (Egg derived)

13/173 Influenza Antigen B/Massachusetts/02/2051 (Egg derived)

10/125 Reteplase Reference Material

07/302 BCG Vaccine of Russian BCG-I sub-strain(29st WHO Reference Reagent)

13/321 Polio Anti Sabin type 104 (inactivated) Serum

12/B623-038 QCRFLUAH1N1QC1-Influenza AH1N1 QC36

13/300 Polio Anti Sabin type 83 (inactivated) Serum

95/570 Interleukin-31 (Human, rDNA derived)

03/104-031 HTLV-16 (antibody) Monitor Sample

更多關于的產品信息，請我司。

国产一级a毛一级a看免费视频,久久久久久国产一级AV片,免费一级做a爰片久久毛片潮,国产精品女人精品久久久天天,99久久久无码国产精品免费了

利拉利汀雜質對照品返回列表頁

化工儀器網

會員登錄

收藏該商鋪

提示